News Roundup

• Santarus files for approval to FDA for anti-swelling drug Rhucin
• Prescription Drug Coverage Is an Important Part of Your Health Care: Medicare Part D Needs to be Considered
• Bone-Damage Concerns Lead to Halt of Pain-Drug Tests -Bloomberg
• FDA Needs Four More Weeks to Review MannKind’s Diabetes Drug Afrezza